Reappraising the Clinical Usability of Consolidation-to-tumor Ratio on CT in Clinical Stage IA Lung Cancer

Overview

Journal Insights Imaging

Publisher Springer

Specialty Radiology

Date 2022 Jun 17

PMID 35715654

Authors

Dong Woog Yoon

Chu Hyun Kim

Soohyun Hwang

Yoon-La Choi

Jong Ho Cho

Hong Kwan Kim

Yong Soo Choi

Jhingook Kim

Young Mog Shim

Sumin Shin

Ho Yun Lee

Affiliations

Soon will be listed here.

Abstract

Objectives: Ground-glass opacity (GGO) on computed tomography is associated with prognosis in early-stage non-small cell lung cancer (NSCLC) patients. However, the stratification of the prognostic value of GGO is controversial. We aimed to evaluate clinicopathologic characteristics of early-stage NSCLC based on the consolidation-to-tumor ratio (CTR), conduct multi-pronged analysis, and stratify prognosis accordingly.

Methods: We retrospectively investigated 944 patients with clinical stage IA NSCLC, who underwent curative-intent lung resection between August 2018 and January 2020. The CTR was measured and used to categorize patients into six groups (1, 0%; 2, 0-25%; 3, 25-50%; 4, 50-75%; 5, 75-100%; and 6, 100%).

Results: Pathologic nodal upstaging was found in 1.8% (group 4), 9.0% (group 5), and 17.4% (group 6), respectively. The proportion of patients with a high grade of tumor-infiltrating lymphocytes tended to decrease as the CTR increased. In a subtype analysis of patients with adenocarcinoma, all of the patients with predominant micro-papillary patterns were in the CTR > 50% groups, and most of the patients with predominant solid patterns were in group 6 (47/50, 94%). The multivariate analysis demonstrated that CTR 75-100% (hazard ratio [HR], 3.85; 95% confidence interval [CI], 1.58-9.36) and CTR 100% (HR, 5.58; 95% CI, 2.45-12.72) were independent prognostic factors for DFS, regardless of tumor size.

Conclusion: We demonstrated that the CTR could provide various noninvasive clinicopathological information. A CTR of more than 75% is the factor associated with a poor prognosis and should be considered when making therapeutic plans for patients with early-stage NSCLC.

Citing Articles

Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer.

Xu Z, Ma Z, Zhao F, Li J, Kong R, Li S Sci Rep. 2024; 14(1):24206.

PMID: 39406938 PMC: 11480474. DOI: 10.1038/s41598-024-76413-x.

Construction of a predictive model of 2-3 cm ground-glass nodules developing into invasive lung adenocarcinoma using high-resolution CT.

Zhang Y, Qu L, Zhang H, Wang Y, Gao G, Wang X Front Med (Lausanne). 2024; 11:1403020.

PMID: 38975053 PMC: 11224554. DOI: 10.3389/fmed.2024.1403020.

Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic Features.

Kim H, Kim J, Hwang S, Oh Y, Ahn J, Kim M Cancer Res Treat. 2024; 57(1):57-69.

PMID: 38938009 PMC: 11729328. DOI: 10.4143/crt.2024.251.

CTR > 0.7 predicts the subgroup of lung adenocarcinomas ≤ 2 cm at risk of poor outcome treated by sublobar resection compared to lobar resection.

Jing W, Li Q, Liu M, Zhang Y, Chen S, Zhang K Cancer Imaging. 2024; 24(1):76.

PMID: 38886780 PMC: 11181521. DOI: 10.1186/s40644-024-00717-4.

Differential efficacy of segmentectomy and wedge resection in sublobar resection compared to lobectomy for solid-dominant stage IA lung cancer: a systematic review and meta-analysis.

Lin H, Peng Z, Zhou K, Liang L, Cao J, Huang Z Int J Surg. 2023; 110(2):1159-1171.

PMID: 37983767 PMC: 10871577. DOI: 10.1097/JS9.0000000000000896.

References

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

Chansky K, Detterbeck F, Nicholson A, Rusch V, Vallieres E, Groome P . The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2017; 12(7):1109-1121. DOI: 10.1016/j.jtho.2017.04.011. View

Lee S, Cho H, Kwon J, Lee H, Park H . Are radiomics features universally applicable to different organs?. Cancer Imaging. 2021; 21(1):31. PMC: 8028225. DOI: 10.1186/s40644-021-00400-y. View

Eguchi T, Kameda K, Lu S, Bott M, Tan K, Montecalvo J . Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis. J Thorac Oncol. 2018; 14(1):87-98. PMC: 6309668. DOI: 10.1016/j.jtho.2018.09.005. View

Gossot D . Lobar or sublobar resection for early-stage lung cancer: at the crossroads. Eur J Cardiothorac Surg. 2021; 60(6):1295-1296. DOI: 10.1093/ejcts/ezab363. View

Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto M . Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg. 2013; 146(1):24-30. DOI: 10.1016/j.jtcvs.2012.12.047. View

Huang T, Lin K, Huang H, Chen Y, Ko K, Chang C . The role of the ground-glass opacity ratio in resected lung adenocarcinoma. Eur J Cardiothorac Surg. 2018; 54(2):229-234. DOI: 10.1093/ejcts/ezy040. View

Veluswamy R, Ezer N, Mhango G, Goodman E, Bonomi M, Neugut A . Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology. J Clin Oncol. 2015; 33(30):3447-53. PMC: 4606062. DOI: 10.1200/JCO.2014.60.6624. View

Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K . Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Ann Thorac Surg. 2017; 104(1):313-320. DOI: 10.1016/j.athoracsur.2017.01.076. View

10.

Shu C, Cascone T . What Is Neo? Chemoimmunotherapy in the Neoadjuvant Setting for Resectable Non-Small-Cell Lung Cancer. J Clin Oncol. 2021; 39(26):2855-2858. DOI: 10.1200/JCO.21.01446. View

11.

Eguchi T, Kadota K, Park B, Travis W, Jones D, Adusumilli P . The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg. 2014; 26(3):210-22. PMC: 4272758. DOI: 10.1053/j.semtcvs.2014.09.002. View

12.

Chen K, Bai J, Reuben A, Zhao H, Kang G, Zhang C . Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity. Am J Respir Crit Care Med. 2021; 204(10):1180-1192. PMC: 8759311. DOI: 10.1164/rccm.202101-0119OC. View

13.

Darling G, Allen M, Decker P, Ballman K, Malthaner R, Inculet R . Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030.... J Thorac Cardiovasc Surg. 2011; 141(3):662-70. PMC: 5082844. DOI: 10.1016/j.jtcvs.2010.11.008. View

14.

Stamatis G, Leschber G, Schwarz B, Brintrup D, Ose C, Weinreich G . Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM.... Lung Cancer. 2019; 138:19-26. DOI: 10.1016/j.lungcan.2019.09.021. View

15.

Travis W . The 2015 WHO classification of lung tumors. Pathologe. 2014; 35 Suppl 2:188. DOI: 10.1007/s00292-014-1974-3. View

16.

Fisher A, Kim S, Farhat D, Belzer K, Milczuk M, French C . Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer. Clin Lung Cancer. 2021; 22(6):e842-e850. PMC: 8536802. DOI: 10.1016/j.cllc.2021.04.004. View

17.

Hattori A, Hirayama S, Matsunaga T, Hayashi T, Takamochi K, Oh S . Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma. J Thorac Oncol. 2018; 14(2):265-275. DOI: 10.1016/j.jtho.2018.09.026. View

18.

Aberle D, Berg C, Black W, Church T, Fagerstrom R, Galen B . The National Lung Screening Trial: overview and study design. Radiology. 2010; 258(1):243-53. PMC: 3009383. DOI: 10.1148/radiol.10091808. View

19.

Cha M, Lee H, Lee K, Jeong J, Han J, Shim Y . Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome. J Thorac Cardiovasc Surg. 2013; 147(3):921-928.e2. DOI: 10.1016/j.jtcvs.2013.09.045. View

20.

Travis W, Asamura H, Bankier A, Beasley M, Detterbeck F, Flieder D . The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016; 11(8):1204-1223. DOI: 10.1016/j.jtho.2016.03.025. View